Skip to main content
SCANCELL HOLDINGS PLC logo

SCANCELL HOLDINGS PLC — Investor Relations & Filings

Ticker · SCLP ISIN · GB00B63D3314 LEI · 2138008RXEG856SNP666 IL Professional, scientific and technical activities
Open in API
Filings indexed 436 across all filing types
Latest filing 2015-07-09 Regulatory Filings
Country GB United Kingdom
Listing IL SCLP

About SCANCELL HOLDINGS PLC

https://www.scancell.co.uk/

Scancell Holdings PLC is a clinical-stage company developing novel active immunotherapies for the treatment of cancer. Its approach focuses on enhancing long-lasting, tumor-specific immunity to address significant unmet needs in oncology, particularly for hard-to-treat cancers. The company leverages its proprietary technology platforms, Immunobody®, Moditope®, and AvidiMab™, to create targeted, off-the-shelf therapies. The Immunobody® platform generates DNA-based immunotherapies, with its lead candidate, iSCIB1+, targeting advanced melanoma. The Moditope® platform develops peptide-based therapies, with a lead product showing encouraging Phase 2 data in a broad range of solid tumors. Scancell aims to deliver treatments that are safe, effective, easily administered, and accessible to patients.

Recent filings

Filing Released Lang Actions
Patient recruitment completed for SCIB1 trial
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content details an operational update regarding a clinical trial ('Patient recruitment completed for SCIB1 Phase 1/2 clinical trial') and includes quotes from management. This type of announcement, which conveys material, non-financial operational news to the market via an official channel, fits the description of a general regulatory filing that doesn't fit a more specific financial category like 10-K, ER, or DIV. Since it is explicitly marked as an RNS release and serves as a general market disclosure, the most appropriate code is RNS.
2015-07-09 English
SCIB1 data update in resected melanoma patients
Legal Proceedings Report Classification · 99% confidence The document begins with 'RNS Number : 8686O' and is dated '02 June 2015'. The content is an announcement providing an 'update on SCIB1 data in resected melanoma patients' presented at the ASCO Annual Meeting. It details clinical trial results, survival times, and immune responses. This format—a brief announcement of positive news, often referencing a presentation or data release, and originating from an RNS service—is characteristic of a general regulatory announcement that doesn't fit the specific categories like 10-K, ER, or IR. Since it is a formal announcement disseminated via the RNS system and serves as a general update, the most appropriate classification is Regulatory Filings (RNS), which acts as a catch-all for such official, non-standard reports.
2015-06-02 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1232 characters) and contains an RNS Number (3540I), indicating it is a regulatory announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational notice regarding market mechanics rather than a standard financial report (like 10-K, IR, or ER). Since it is a specific regulatory announcement that doesn't fit the defined categories like AGM-R, 10-K, ER, or DIV, the most appropriate fallback category is 'Regulatory Filings' (RNS).
2015-03-24 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1190 characters) and announces a specific, temporary market event: a 'Price Monitoring Extension' for the closing auction call period of the security. It explicitly states that the information is provided by 'RNS' (the company news service from the London Stock Exchange) and carries an 'RNS Number'. This is a general regulatory announcement concerning trading mechanics rather than a substantive financial report (like 10-K, ER, or IR) or a specific corporate action (like DIV or DIRS). Given its nature as a routine, non-standard regulatory notice, the most appropriate classification is the general regulatory fallback category.
2015-03-24 English
SCIB2 synergy with checkpoint inhibitor blockade
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated March 24, 2015. The content is an announcement regarding new pre-clinical data for a cancer immunotherapy (SCIB2) showing synergy with checkpoint inhibitors. This is a typical structure for a company releasing material news to the market via an official channel. Since it is a general announcement of scientific/business progress that doesn't fit specific categories like ER, 10-K, or DIV, and it is explicitly marked as originating from 'RNS' (The company news service from the London Stock Exchange), the most appropriate classification is the general regulatory filing/announcement category.
2015-03-24 English
Positive SCIB1 Phase 1/2 clinical trial update
Legal Proceedings Report Classification · 99% confidence The document is identified by the 'RNS Number' header and the concluding statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces that company executives will provide a clinical trial update during corporate presentations at an external conference (JP Morgan's 33rd Annual Healthcare Conference). This is a general announcement of company news released via the Regulatory News Service (RNS). Since it is not a full report (like 10-K or IR) but a brief announcement of ongoing events and preliminary data, and it is explicitly marked as an RNS release, the most appropriate classification is RNS, which serves as the general regulatory announcement fallback.
2015-01-12 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.